MLB: No Biogenesis discipline for Miguel Tejada
Major League Baseball released a statement Wednesday clearing Miguel Tejada of any discipline involving the Biogenesis scandal.
“The Office of the Commissioner investigated all allegations regarding players associated with Anthony Bosch and Biogenesis. The investigation found no violation by Miguel Tejada of the Joint Drug Prevention and Treatment Program.”
On Saturday, MLB suspended the Royals’ infielder 105 games after he tested positive for amphetamines on multiple occasions. Tejada claimed he had a therapeutic use exemption for the drug Adderall that was not renewed.
Pedro Gomez of ESPN reported Tuesday that Biogenesis evidence also implicated Tejada’s purchase of performance-enhancing drugs through the Miami clinic that has since closed.
Major League Baseball had the choice of going after the 2002 American League MVP for the Biogenesis case, as the league did 13 other players earlier this month, or for the amphetamine case. MLB chose to suspend Tejada after he tested positive for a third time in his career for amphetamines.
Tejada, according to a source familiar with the case, was given the choice of either accepting the 105-game suspension for amphetamine use or facing additional punishment for his Biogenesis connection. Tejada was allegedly a customer of Tony Bosch’s shuttered clinic, which is at the heart of baseball’s recent rash of suspensions. Bosch supplied evidence that Tejada had been a Biogenesis customer.